Read More 5 minute read Pharma Industry News Is dose escalation the new edge in the obesity drug war? Why GLP-1 rivals are raising the ceiling on efficacy High-dose GLP-1 drugs like 7.2 mg Wegovy are redefining obesity treatment in 2025. Find out how dose escalation is shifting efficacy expectations. byVenkateshDecember 1, 2025